Are oncoantigens suitable targets for anti-tumour therapy? (Q28240977)

Targeting melanoma cells with human high molecular weight-melanoma associated antigen-specific antibodies elicited by a peptide mimotope: functional effects

Europe PubMed Central

title

Are oncoantigens suitable targets for anti-tumour therapy? (English)

0 references

author

Raffaele A. Calogero

object named as

Raffaele Adolfo Calogero

series ordinal

2

0 references

Federica Cavallo

object named as

Federica Cavallo

series ordinal

1

0 references

author name string

Guido Forni

series ordinal

3

0 references

language of work or name

English

0 references

publication date

September 2007

0 references

published in

Nature Reviews Cancer

0 references

volume

7

0 references

issue

9

0 references

page(s)

707-13

0 references

cites work

1 reference

Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent

21 January 2018

1 reference

Early role of CD4+ Th1 cells and antibodies in HER-2 adenovirus vaccine protection against autochthonous mammary carcinomas.

21 January 2018

1 reference

Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression.

21 January 2018

1 reference

Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma

21 January 2018

1 reference

Selecting targets for cancer prevention: where do we go from here?

21 January 2018

1 reference

31 March 2020

Fibroblasts in cancer

1 reference

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

31 March 2020

1 reference

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

31 March 2020

1 reference

Increased surveillance of cells in mitosis by human NK cells suggests a novel strategy for limiting tumor growth and viral replication

31 March 2020

1 reference

Cancer as an evolutionary and ecological process

31 March 2020

1 reference

Cancer immunoediting: from immunosurveillance to tumor escape

31 March 2020

1 reference

Premalignant lesions as targets for cancer vaccines

31 March 2020

1 reference

Vaccines for tumour prevention

31 March 2020

1 reference

Cancer vaccines: between the idea and the reality

31 March 2020

1 reference

Cancer immunoprevention: tracking down persistent tumor antigens

31 March 2020

1 reference

p185(neu) protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma

31 March 2020

1 reference

A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth

31 March 2020

1 reference

Targeting VEGF-A to treat cancer and age-related macular degeneration

31 March 2020

1 reference

Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy

31 March 2020

1 reference

Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice

31 March 2020

1 reference

Untangling the ErbB signalling network

31 March 2020

1 reference

Invasive growth: a MET-driven genetic programme for cancer and stem cells

31 March 2020

1 reference

Cancer phenomics: RET and PTEN as illustrative models

31 March 2020

1 reference

The chimeric anti-CD20 antibody rituximab induces apoptosis in B-cell chronic lymphocytic leukemia cells through a p38 mitogen activated protein-kinase-dependent mechanism

31 March 2020

1 reference

High throughput proteomic strategies for identifying tumour-associated antigens

31 March 2020

1 reference

Analysis of the B-cell repertoire against antigens expressed by human neoplasms

31 March 2020

1 reference

Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model

31 March 2020

1 reference

Genomic approach to biomarker identification and its recent applications

31 March 2020

1 reference

A new generation of mouse models of cancer for translational research

31 March 2020

1 reference

Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice

31 March 2020

1 reference

Patterns of somatic mutation in human cancer genomes

31 March 2020

1 reference

Rebuilding the road to cancer.

31 March 2020

1 reference

Repression of protein synthesis by miRNAs: how many mechanisms?

31 March 2020

1 reference

Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA

31 March 2020

1 reference

A human protein atlas for normal and cancer tissues based on antibody proteomics

31 March 2020

1 reference

An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention

31 March 2020

1 reference

NCBI GEO: mining tens of millions of expression profiles--database and tools update

31 March 2020

1 reference

ArrayExpress--a public database of microarray experiments and gene expression profiles

31 March 2020

1 reference

Prediction of cancer outcome with microarrays: a multiple random validation strategy

31 March 2020

1 reference

High-throughput genomic technology in research and clinical management of breast cancer. Exploiting the potential of gene expression profiling: is it ready for the clinic?

31 March 2020

1 reference

A gene expression signature predicts survival of patients with stage I non-small cell lung cancer

31 March 2020

1 reference

Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis

31 March 2020

1 reference

Meta-analysis for microarray studies of the genetics of complex traits

31 March 2020

1 reference

Gene expression microarrays: glimpses of the immunological genome.

31 March 2020

1 reference

Gene expression profiling predicts clinical outcome of breast cancer

31 March 2020

1 reference

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

31 March 2020

1 reference

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

31 March 2020

1 reference

MUC1 immunobiology: from discovery to clinical applications

31 March 2020

1 reference

Contribution of membrane mucins to tumor progression through modulation of cellular growth signaling pathways

31 March 2020

1 reference

Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene

31 March 2020

1 reference

Tyrosines in the MUC1 cytoplasmic tail modulate transcription via the extracellular signal-regulated kinase 1/2 and nuclear factor-kappaB pathways

31 March 2020

1 reference

Cell surface-associated mucins in signal transduction

31 March 2020

1 reference

Immunosurveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance

31 March 2020

1 reference

Distinct and non-overlapping T cell receptor repertoires expanded by DNA vaccination in wild-type and HER-2 transgenic BALB/c mice

31 March 2020

1 reference

Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice

31 March 2020

1 reference

High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer

31 March 2020

1 reference

Intratumoral T-cell infiltrates and MHC class I expression in patients with stage IV melanoma

31 March 2020

1 reference

CD8(+) T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function

31 March 2020

1 reference

Comparing antibody and small-molecule therapies for cancer

31 March 2020

1 reference

Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.

31 March 2020

1 reference

Regulation of immune responses by L-arginine metabolism

31 March 2020

1 reference

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells

31 March 2020

1 reference

The CD8+ T cell repertoire against Her-2/neu antigens in neu transgenic mice is of low avidity with antitumor activity

31 March 2020

1 reference

Vaccination for treatment and prevention of cancer in animal models.

31 March 2020

1 reference

Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.

31 March 2020

1 reference

Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions

31 March 2020

1 reference

31 March 2020

Drivers and passengers

1 reference

The consensus coding sequences of human breast and colorectal cancers

31 March 2020

1 reference

Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis

31 March 2020

1 reference

Roadmap to a better therapeutic tumor vaccine

31 March 2020

1 reference

The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigens

31 March 2020

1 reference

Immunobiology of her-2/neu transgenic mice.

31 March 2020

1 reference

Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario.

31 March 2020

1 reference

Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity

31 March 2020

1 reference

New insights into oncogene addiction found

31 March 2020

1 reference

Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response

31 March 2020

1 reference

The tumour microenvironment as a target for chemoprevention.

31 March 2020

1 reference